Abbott Laboratories Acquires Evalve for $410,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    4045 Campbell Ave Menlo Park, CA 94025
  • Company Description
    Evalve, Inc. is a leader in innovative devices for the endovascular repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and costs associated with current open, arrested heart surgical options.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The deal includes a $320 million up-front payment, plus another $90 million in possible earnouts.

Trending on Xconomy